Nuvectis Pharma, Inc. (NVCT)
NASDAQ·Healthcare·Biotechnology
$20.46
-5.30%
Mkt Cap $571.06M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
-51.1%
Consensus $10.00 vs current $20.46
NASDAQ·Healthcare·Biotechnology
$20.46
-5.30%
Mkt Cap $571.06M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
-51.1%
Consensus $10.00 vs current $20.46